据CDC数据显示，针对美国面临的人类免疫缺陷病毒（HIV）的公共卫生问题，截至2019年底估计有120万人感染HIV。HIV仍无法治愈，但抗逆转录病毒疗法（ART）在控制疾病进展、改善生活质量和延长寿命方面已经取得了有效成果。ART通常由3种或更多药 ...

Real-world analyses have confirmed the efficacy of the 2-drug regimen of dolutegravir and lamivudine in treating HIV, ...

所有HIV 感染者均应接受抗逆转录病毒治疗（ART），整合酶抑制剂（INSTIs）比克恩丙诺（BIC）或多替拉韦（DTG）被推荐用于大多数 HIV 感染者的初始 ...

This Collection will feature original research on the prevention and treatment of HIV, including the development and use of new PrEP, PEP, and ART options and current approaches to diagnosis ...

but use of any ART combination approved by the FDA for initial treatment of HIV infection was allowed. All patients in the early group and 91% of those in the delayed group actually initiated ART ...

This study complements ACTG's PAUSE study, which is evaluating two very similar bNAbs among people living with HIV who have ...

Among treatment-naive people with HIV, dolutegravir/lamivudine showed viral suppression comparable with those of other ...

Discover the latest advancements in HIV prevention and how they offer hope for reducing infections, especially in the Black ...